The JI
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     
 


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Grayson, J. M.
Right arrow Articles by Ahmed, R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Grayson, J. M.
Right arrow Articles by Ahmed, R.
The Journal of Immunology, 2003, 170: 4745-4751.
Copyright © 2003 by The American Association of Immunologists

Mitochondrial Potential and Reactive Oxygen Intermediates in Antigen-Specific CD8+ T Cells During Viral Infection1

Jason M. Grayson2, Nathan G. Laniewski, J. Gibson Lanier3 and Rafi Ahmed3

Department of Microbiology and Immunology, Wake Forest University School of Medicine, Winston-Salem, NC 27157

Following many viral infections, there are large expansions of Ag-specific CD8+ T cells. After viral clearance, mechanisms exist to ensure that the vast majority of effector cells undergo apoptosis. In studies of thymocyte apoptosis, loss of mitochondrial potential ({Delta}{Psi}m) and excess production of reactive oxygen intermediates have been implicated as key events in cellular apoptosis. The purpose of the experiments presented in this work was to determine these parameters in Ag-specific CD8+ T cells during a physiological response such as viral infection. Using lymphocytic choriomeningitis virus infection of mice, we found that Ag-specific CD8+ effector T cells that had undergone recent TCR stimulation had an increased {Delta}{Psi}m. These cells also had increased levels of superoxide. As these cells progressed through the contraction of the immune response, their potential decreased, but superoxide levels remained similar to naive cells. One of the consequences of reduced mitochondrial potential is membrane permeability and subsequent caspase activation. We examined both the enzymatic activity and levels of cleaved caspase 3, an effector caspase, and could only detect increased levels in Ag-specific CD8+ T cells on day 5 postinfection, a time point in which virus was still present. This contrasts with Ag-specific effector cells examined during the contraction phase that had no detectable caspase activity directly ex vivo. These data suggest that the apoptotic program begins earlier than previously expected on day 5, during the expansion phase.




This article has been cited by other articles:


Home page
J. Immunol.Home page
R. D. Michalek, K. J. Nelson, B. C. Holbrook, J. S. Yi, D. Stridiron, L. W. Daniel, J. S. Fetrow, S. B. King, L. B. Poole, and J. M. Grayson
The Requirement of Reversible Cysteine Sulfenic Acid Formation for T Cell Activation and Function
J. Immunol., November 15, 2007; 179(10): 6456 - 6467.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
P. R. Hess, C. Barnes, M. D. Woolard, M. D. L. Johnson, J. M. Cullen, E. J. Collins, and J. A. Frelinger
Selective deletion of antigen-specific CD8+ T cells by MHC class I tetramers coupled to the type I ribosome-inactivating protein saporin
Blood, April 15, 2007; 109(8): 3300 - 3307.
[Abstract] [Full Text] [PDF]


Home page
J. Leukoc. Biol.Home page
S. Mehrotra, A. Chhabra, U. Hegde, N. G. Chakraborty, and B. Mukherji
Inhibition of c-Jun N-terminal kinase rescues influenza epitope-specific human cytolytic T lymphocytes from activation-induced cell death
J. Leukoc. Biol., February 1, 2007; 81(2): 539 - 547.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
J. S. Yi, B. C. Holbrook, R. D. Michalek, N. G. Laniewski, and J. M. Grayson
Electron Transport Complex I Is Required for CD8+ T Cell Function
J. Immunol., July 15, 2006; 177(2): 852 - 862.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
D. C. Bullard, X. Hu, T. R. Schoeb, R. C. Axtell, C. Raman, and S. R. Barnum
Critical Requirement of CD11b (Mac-1) on T Cells and Accessory Cells for Development of Experimental Autoimmune Encephalomyelitis
J. Immunol., November 15, 2005; 175(10): 6327 - 6333.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
M. Cebecauer, P. Guillaume, P. Hozak, S. Mark, H. Everett, P. Schneider, and I. F. Luescher
Soluble MHC-Peptide Complexes Induce Rapid Death of CD8+ CTL
J. Immunol., June 1, 2005; 174(11): 6809 - 6819.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
D. F. Gaddy and D. S. Lyles
Vesicular Stomatitis Viruses Expressing Wild-Type or Mutant M Proteins Activate Apoptosis through Distinct Pathways
J. Virol., April 1, 2005; 79(7): 4170 - 4179.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
A. K. Nussbaum and J. L. Whitton
The Contraction Phase of Virus-Specific CD8+ T Cells Is Unaffected by a Pan-Caspase Inhibitor
J. Immunol., December 1, 2004; 173(11): 6611 - 6618.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
S. Mehrotra, A. Chhabra, S. Chattopadhyay, D. I. Dorsky, N. G. Chakraborty, and B. Mukherji
Rescuing Melanoma Epitope-Specific Cytolytic T Lymphocytes from Activation-Induced Cell Death, by SP600125, an Inhibitor of JNK: Implications in Cancer Immunotherapy
J. Immunol., November 15, 2004; 173(10): 6017 - 6024.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
N. G. Laniewski and J. M. Grayson
Antioxidant Treatment Reduces Expansion and Contraction of Antigen-Specific CD8+ T Cells during Primary but Not Secondary Viral Infection
J. Virol., October 15, 2004; 78(20): 11246 - 11257.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
X. Z. Wang, M. A. Brehm, and R. M. Welsh
Preapoptotic Phenotype of Viral Epitope-Specific CD8 T Cells Precludes Memory Development and Is an Intrinsic Property of the Epitope
J. Immunol., October 15, 2004; 173(8): 5138 - 5147.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Website Copyright © 2003 by The American Association of Immunologists, Inc. All rights reserved.
All Contents Copyright © 2003 by The American Association of Immunologists, Inc. All rights reserved.